There is no panel matching the key "Alert"

DCP-001

Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

Study Status: Open to enrollment

Why is this study being done?
The purpose of this project is to understand why patients do not participate in clinical trials. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations.

Who is eligible to participate? (sex, age, health status, other)
Eligible patients will meet the following criteria:

  • All adult patients screened for selected NCORP trials supported by the Division of Cancer Prevention (DCP). These trials include symptom and toxicity management, prevention, screening, post-treatment surveillance and comparative effectiveness. Cancer care delivery clinical trials will be included if the primary aim focuses on a patient intervention. A screened patient will be defined as one meeting the following minimum eligibility criteria per the protocol being screened for: a) Cancer diagnosis including stage and histology or pre-malignancy b) Age range specified in the protocol for which the patient is being screened c) Indication for the study intervention (e.g., symptom, toxicity)
  • A legally authorized representative may consent for a participant with impaired decision making.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Love + Medicine

Every day, Gundersen Health System delivers great medicine plus a little something extra—we call it Love + Medicine.

Share Your Story